EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The pathogenesis of gut microbiota in hepatic encephalopathy by the gut–liver–brain axis

Ruirui Zhu, Liwen Liu, Guizhen Zhang, Jianxia Dong, Zhigang Ren iD, Zhiqin Li

Bioscience Reports · 28.06.2023 · 43 (6)

DOI: 10.1042/bsr20222524 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioscience Reports, online erschienen am 15.06.2023. Verfasst von Ruirui Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China. Hauptthemen laut MEDLINE: Hepatic Encephalopathy, Gastrointestinal Microbiome, Hyperammonemia. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatic encephalopathy (HE) is a neurological disease occurring in patients with hepatic insufficiency and/or portal-systemic blood shunting based on cirrhosis. The pathogenesis is not completely clear till now, but it is believed that hyperammonemia is the core of HE. Hyperammonemia caused by increased sources of ammonia and decreased metabolism further causes mental problems through the gut–liver–brain axis. The vagal pathway also plays a bidirectional role in the axis. Intestinal microorganisms play an important role in the pathogenesis of HE through the gut–liver–brain axis. With the progression of cirrhosis to HE, intestinal microbial composition changes gradually. It shows the decrease of potential beneficial taxa and the overgrowth of potential pathogenic taxa. Changes in gut microbiota may lead to a variety of effects, such as reduced production of short-chain fatty acids (SCFAs), reduced production of bile acids, increased intestinal barrier permeability, and bacterial translocation. The treatment aim of HE is to decrease intestinal ammonia production and intestinal absorption of ammonia. Prebiotics, probiotics, antibiotics, and fecal microbiota transplantation (FMT) can be used to manipulate the gut microbiome to improve hyperammonemia and endotoxemia. Especially the application of FMT, it has become a new treated approach to target microbial composition and function. Therefore, restoring intestinal microbial homeostasis can improve the cognitive impairment of HE, which is a potential treatment method.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatic EncephalopathyGastrointestinal MicrobiomeHyperammonemiaHumansAmmoniaLiver CirrhosisFibrosisBrain

Stichwörter der Autor:innen

Fecal microbiota transplantationGut microbiotaGut-brain-liver axisHyperammonemia

Substanzen

Ammonia

Autor:innen und Institutionen

  • Department of Infectious Diseases, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
  • Gene Hospital of Henan Province; Precision Medicine Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
  • Jinan Microecological Biomedicine Shandong Laboratory, Jinan 250000, China.

ORCID-Profile: Zhigang Ren

Zitieren

APA

Zhu, R., Liu, L., Zhang, G., Dong, J., Ren, Z., & Li, Z. (2023). The pathogenesis of gut microbiota in hepatic encephalopathy by the gut–liver–brain axis. Bioscience Reports, 43(6). https://doi.org/10.1042/bsr20222524

Vancouver

Zhu R, Liu L, Zhang G, Dong J, Ren Z, Li Z. The pathogenesis of gut microbiota in hepatic encephalopathy by the gut–liver–brain axis. Bioscience Reports. 2023;43(6). doi:10.1042/bsr20222524

BibTeX
@article{Zhu2023,
  author = {Zhu, Ruirui and Liu, Liwen and Zhang, Guizhen and Dong, Jianxia and Ren, Zhigang and Li, Zhiqin},
  title = {The pathogenesis of gut microbiota in hepatic encephalopathy by the gut–liver–brain axis},
  journal = {Bioscience Reports},
  year = {2023},
  volume = {43},
  number = {6},
  doi = {10.1042/bsr20222524}
}
Kostenlos starten →